Aurobindo Pharma Shares Drop 3% After Fire at Kakinada Facility

Market Movement on April 29

Aurobindo Pharma shares witnessed a sharp decline of over 3% in early trade on April 29, 2025, following a reported fire incident at one of its key manufacturing units.

• Stock Price: ₹1,211 apiece on BSE at 10 AM
• 52-Week High: ₹1,592
• 52-Week Low: ₹1,010
• Market Capitalisation: ₹70,400 crore

Fire Breaks Out at Kakinada Facility

The pharmaceutical major confirmed a fire at its Penicillin-G Manufacturing Facility in the Kakinada SEZ, Andhra Pradesh. The fire, which broke out around 10:00 PM IST on April 27, was restricted to the coal crusher area.

Key Details:

• No injuries were reported.
• Core manufacturing infrastructure remained unaffected.
• Ancillary equipment suffered damage.
• The self-ignition of coal caused the fire.
• The facility is fully insured.

Temporary Halt in Operations

Operations at the Kakinada facility will be paused for 20–25 days to facilitate equipment replacement and safety assessment.

According to the company's regulatory filing:

• A thorough damage evaluation is currently underway.
• The incident is not expected to impact the group's operations or financials materially.

Company Profile: Aurobindo Pharma

Aurobindo Pharma is a leading Indian pharmaceutical company known for its wide portfolio of generic medications and APIs. The firm has a strong presence in both domestic and international markets, focusing on research-driven production and regulatory compliance.

Summary

The recent fire at Aurobindo Pharma's Kakinada facility led to a 3% drop in stock price. Still, with no injuries and minimal disruption to core operations, the long-term impact appears limited. The company has assured stakeholders that the situation is under control and that production will resume after necessary repairs.